Serum biomarkers of hepatitis B virus infected liver inflammation: A proteomic study
Authors:
- Qing‐Yu HeQHQing‐Yu He
- George K. K. LauGLGeorge K. K. Lau
- Yuan ZhouYZYuan Zhou
- Marie C. LinMLMarie C. Lin
- Hsiang‐Fu KungHKHsiang‐Fu Kung
- Jen‐Fu ChiuJCJen‐Fu Chiu
- 8 May 2003
- journal article
- research article
- Published by Wiley in Proteomics
- Vol. 3 (5) , 666-674
Abstract
Hepatitis B virus (HBV), a serious infectious and widespread human pathogen, represents a major health problem worldwide. Chronic HBV infection has a very high risk of evolving into hepatocellular carcinoma. Although considerable progress was made during the recent past, the pathogenesis of HBV infection is still elusive and a definite diagnosis of HBV infected liver information still relies on biopsy histological test. In this report, we used proteomics technology to globally examine HBV infected serum samples aiming at searching for disease‐associated proteins that can be used as serological biomarkers for diagnosis and/or target proteins for pathogenetic study. By comparing with normal and HBV negative serum samples, we found that at least seven proteins were significantly changed in HBV infected sera. These greatly altered proteins were identified to be haptoglobin β and α2 chain, apolipoprotein A‐I and A‐IV, α1‐antitrypsin, transthyretin and DNA topoisomerase IIβ. The alteration of these proteins is displayed not only in quantity but also in patterns (or specificity), which can be correlated with necroinflammatory scores. In particular, apolipoprotein A‐I presents heterogeneous change in expression level with different isoforms and α1‐antitrypsin produces evidently different fragments implying diverse cleavage pathways. These unique phenomena appear specific to HBV infection. A combination simultaneously considering the quantities and isoforms of these proteins could be a useful serum biomarker (or index) for HBV diagnosis and therapy.Keywords
This publication has 40 references indexed in Scilit:
- THE ROLE OF APOLIPOPROTEIN A-IV IN THE REGULATION OF FOOD INTAKEAnnual Review of Nutrition, 2001
- Topoisomerase IIα and other drug resistance markers in advanced non-small cell lung cancerLung Cancer, 2001
- Apolipoprotein AI isoforms in serum determined by isoelectric focusing and immunoblottingElectrophoresis, 1997
- Reduction of intestinal apo A‐IV mRNA levels in the cirrhotic ratJournal of Gastroenterology and Hepatology, 1996
- New Alterations of Serum Glycoproteins in Alcoholic and Cirrhotic Patients Revealed by High Resolution Two-Dimensional Gel ElectrophoresisBiochemical and Biophysical Research Communications, 1996
- Proteolytic Inactivation of alpha1-Proteinase Inhibitor in vivo: Detection, Characterization and Quantitation of the Main Fragment Excreted in the Urine of Leukemia PatientsBiological Chemistry Hoppe-Seyler, 1992
- Serum apoproteins A and B and the lecithin: Cholesterol acyl transferase activities in liver cirrhosis and hepatic coma patientsBiochemical Medicine and Metabolic Biology, 1988
- Acute phase proteins in chronic and malignant liver diseasesLiver International, 1988
- Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis†Hepatology, 1981
- Haptoglobin- und Group-specific Component-Merkmale bei nicht erkrankten Antikörperträgern gegen Hepatitis B Surface AntigenAnnals of Hematology, 1978